Ion Exchange (500214) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
10 Aug, 2026Company overview and global presence
Over 62 years of expertise in water and environment management, operating in 50+ countries with 200,000+ installations worldwide.
Advanced R&D centers in India and global assembly hubs in UAE, Saudi Arabia, South Africa, Indonesia, and Bangladesh.
One of Asia's largest service networks, serving industries, institutions, homes, and communities.
14 global manufacturing facilities and assembly centers, with 30% of revenue from international markets.
Projects executed across South Asia, West Asia, Africa, East Asia, Southeast Asia, Europe, and Latin America.
Solutions and portfolio
Comprehensive offerings include ion exchange resins, membranes, chemicals, standard systems, home water solutions, and digital solutions.
Solutions span source water, process water, high purity water, ultrapure water, wastewater, zero liquid discharge, and municipal/sewage treatment.
Advanced solutions cover seawater desalination, advanced oxidation, wellness solutions, and specialized industrial applications.
Emerging solutions focus on brine valorization, lithium extraction, PFAS assurance, new energy, semiconductor, and data center solutions.
Innovation and investments
Over 50 years of R&D legacy, with 100+ patents and more than 100 products launched.
Strategic investments in expanding resin, membrane, and standard systems manufacturing capacities.
India's first non-solvent resin and integrated RO membrane manufacturing facilities established.
Circular manufacturing initiatives with integrated acid recovery and green operations.
Expanded pharma resin portfolio and capacity, reducing import dependence and supporting long-term growth.
Latest events from Ion Exchange
- Revenue up 20% YoY, but margins and profit down; order book and strategy support future growth.500214
Q1 26/27 - Q1 FY25 delivered double-digit revenue and profit growth, with strong segment performance.500214
Q1 24/25 - Strong revenue and profit growth in Q2/H1 FY25; future outlook robust despite key risks.500214
Q2 24/25 - Strong revenue and profit growth, led by Engineering and Chemicals, despite margin pressures.500214
Q3 24/25 - Revenue and profit rose year-over-year, with a ₹1.50 dividend and robust segment growth.500214
Q4 24/25 - Q1 FY26 saw higher revenue and profit, stable margins, and Roha plant set to boost exports.500214
Q1 25/26 - Revenue up, margins pressured; Roha plant, new orders, and SEBI litigation shape outlook.500214
Q2 25/26 - Revenue up, margins and profits down due to costs and Labour Codes; SEBI case ongoing.500214
Q3 25/26 - FY26 revenue rose 6.5% but net profit fell on margin pressure and legal, regulatory risks.500214
Q4 25/26